000893193 001__ 893193
000893193 005__ 20210623133503.0
000893193 0247_ $$2doi$$a10.1055/a-1380-7815
000893193 0247_ $$2ISSN$$a0723-7065
000893193 0247_ $$2ISSN$$a1439-5800
000893193 0247_ $$2Handle$$a2128/27955
000893193 037__ $$aFZJ-2021-02617
000893193 082__ $$a610
000893193 1001_ $$0P:(DE-Juel1)166419$$aNeumaier, Bernd$$b0$$eCorresponding author$$ufzj
000893193 245__ $$aMöglichkeiten und Grenzen der Nutzung kleiner Zyklotrone bei der Produktion medizinisch relevanter Radionuklide
000893193 260__ $$aStuttgart$$bThieme$$c2021
000893193 3367_ $$2DRIVER$$aarticle
000893193 3367_ $$2DataCite$$aOutput Types/Journal article
000893193 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article$$bjournal$$mjournal$$s1623823629_15032
000893193 3367_ $$2BibTeX$$aARTICLE
000893193 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000893193 3367_ $$00$$2EndNote$$aJournal Article
000893193 520__ $$aRadionuclides for in vivo imaging studies as well as for internal radiotherapy are produced using both nuclear reactors and cyclotrons. In this contribution we discuss the possibilities of production of different types of radionuclides using a small medical cyclotron (Ep = 18 MeV; Ed = 9 MeV). Besides routine production of short-lived “standard” positron emitters 11C, 15O and 18F, several “non-standard” positron emitters like 64Cu, 86Y, 89Zr etc. could also be produced in quantities sufficient for extended positron emission tomography. It is, however, necessary to develop a suitable target system for irradiation of enriched material. In principle, it is then also possible to produce in small amounts a few SPECT radionuclides (67Ga, 111In, 123I) as well as therapy-related radionuclides (67Cu, 103Pd, 186Re)
000893193 536__ $$0G:(DE-HGF)POF4-525$$a525 - Decoding Brain Organization and Dysfunction (POF4-525)$$cPOF4-525$$fPOF IV$$x0
000893193 588__ $$aDataset connected to CrossRef, Journals: juser.fz-juelich.de
000893193 7001_ $$0P:(DE-Juel1)131849$$aSpahn, Ingo$$b1$$ufzj
000893193 7001_ $$0P:(DE-Juel1)131840$$aQaim, Syed M.$$b2$$ufzj
000893193 773__ $$0PERI:(DE-600)2092413-6$$a10.1055/a-1380-7815$$gVol. 44, no. 02, p. 120 - 126$$n02$$p120 - 126$$tDer @Nuklearmediziner$$v44$$x0723-7065$$y2021
000893193 8564_ $$uhttps://juser.fz-juelich.de/record/893193/files/Autorenversion.docx$$yPublished on 2021-06-10. Available in OpenAccess from 2022-06-10.
000893193 909CO $$ooai:juser.fz-juelich.de:893193$$pdnbdelivery$$pdriver$$pVDB$$popen_access$$popenaire
000893193 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)166419$$aForschungszentrum Jülich$$b0$$kFZJ
000893193 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131849$$aForschungszentrum Jülich$$b1$$kFZJ
000893193 9101_ $$0I:(DE-588b)5008462-8$$6P:(DE-Juel1)131840$$aForschungszentrum Jülich$$b2$$kFZJ
000893193 9130_ $$0G:(DE-HGF)POF3-573$$1G:(DE-HGF)POF3-570$$2G:(DE-HGF)POF3-500$$3G:(DE-HGF)POF3$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lDecoding the Human Brain$$vNeuroimaging$$x0
000893193 9131_ $$0G:(DE-HGF)POF4-525$$1G:(DE-HGF)POF4-520$$2G:(DE-HGF)POF4-500$$3G:(DE-HGF)POF4$$4G:(DE-HGF)POF$$aDE-HGF$$bKey Technologies$$lNatural, Artificial and Cognitive Information Processing$$vDecoding Brain Organization and Dysfunction$$x0
000893193 9141_ $$y2021
000893193 915__ $$0StatID:(DE-HGF)0530$$2StatID$$aEmbargoed OpenAccess
000893193 915__ $$0StatID:(DE-HGF)0020$$2StatID$$aNo Peer Review
000893193 920__ $$lyes
000893193 9201_ $$0I:(DE-Juel1)INM-5-20090406$$kINM-5$$lNuklearchemie$$x0
000893193 980__ $$ajournal
000893193 980__ $$aVDB
000893193 980__ $$aUNRESTRICTED
000893193 980__ $$aI:(DE-Juel1)INM-5-20090406
000893193 9801_ $$aFullTexts